News
MEDIA INQUIRIES
Please contact Colleen O’Malley, Sr. Director, Marketing & Communications, ABTA at 773-577-8750.
ABTA Press Releases
ABTA Announces $50-Million Fundraising Campaign to Accelerate Research, Improve Lives of Brain Tumor Patients
A champion of the brain tumor community for 50 years running, the American Brain Tumor Association (ABTA) has launched its most ambitious undertaking yet – a five-year, $50-million fundraising campaign called Meet Hope Head On.
The Meet Hope Head On campaign will focus on three pillars: tripling the ABTA’s research investment, doubling the number of patients served, and doubling federal funding for brain tumor research. Throughout its 50-year history, the ABTA has provided vital seed money to fund high-risk, high-reward research grants which have contributed to significant breakthroughs in treating brain tumors by many of the country’s leading researchers.
American Brain Tumor Association Announces New Board of Directors Chair, Officers and Member
Meet the newly-appointed ABTA Board Chair and Member and discover what they’re hopeful for in their new roles.
American Brain Tumor Association Partners with Brain Tumour Foundation of Canada on Low-Grade Glioma Research
The American Brain Tumor Association (ABTA) today announced a new partnership with Brain Tumour Foundation of Canada (BTFC) to accelerate brain tumor research. Through this partnership, BTFC will invest in the ABTA research program to co-fund a research project in Canada, focused on improving resection for low-grade glioma.
American Brain Tumor Association Awards 20 Research Grants to Advance Brain Tumor Science and Discoveries
The American Brain Tumor Association (ABTA) today announced the funding of $821,000 towards 20 new research grants to advance brain tumor science and treatments. With more than $34 million invested in research to date, across all brain tumor types and ages, the ABTA research program plays a critical role in advancing the understanding of brain tumors and building the next generation of brain tumor researchers.
